PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Tiny antisense molecules increase 'good cholesterol' levels in obese primates

Targeting shared nucleotide sequences can suppress family of gene-regulating microRNAs

2013-11-21
(Press-News.org) Contact information: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Tiny antisense molecules increase 'good cholesterol' levels in obese primates Targeting shared nucleotide sequences can suppress family of gene-regulating microRNAs A strategy developed by Massachusetts General Hospital (MGH)-based investigators to increase levels of beneficial high-density lipoprotein (HDL) has been shown for the first time to be effective in non-human primates. The approach uses tiny antisense sequences to block the action of microRNAs that would otherwise inhibit a protein required for generation of HDL, the "good cholesterol" that helps remove harmful lipids from the body. The report appears in the November 20 Science Translational Medicine.

"We have found that targeting both members of the miR-33 microRNA family with a tiny, 8-nucleotide anti-microRNA can increase HDL levels by almost 40 percent," says Anders Näär, PhD, of the MGH Center for Cancer Research, who led the study. "This sets the stage for new therapeutic strategies to treat cardiovascular disease in humans and provides a template for targeting other disease-associated microRNA families."

Major regulators of gene expression, microRNAs are segments made up of 20- to 24-nucleotides that bind to complementary strands of messenger RNA, blocking their translation into proteins. A 2010 study led by Näär identified two related microRNAs – miR-33a and miR-33b – that inhibit a protein called ABCA1, which is essential for both the generation of HDL and for the transport of lipids to the liver. Treatment with miR-33-blocking antisense molecules was able to increase HDL levels in mice, but rodents have only one form of the microRNA. If the two versions of miR-33 carried by humans and other primates have redundant effects – that is if they both act to inhibit ABCA1 – blocking only a single version would be ineffective.

An earlier study by Näär's team showed that use of an 8-nucleotide anti-microRNA targeting only the "seed" sequence that is shared among related microRNAs could inhibit all members of a family. Before investigating the use of such an approach in humans, the researchers tested its feasibility in 20 obese and insulin resistant African green monkeys. The animals were divided into four groups, three of which received weekly injections of anti-microRNAs targeting either miR-33a, miR-33b or the seed sequence shared by both versions. The fourth group received inert control injections.

After nearly four months, HDL levels in animals receiving anti-microRNA targeting the seed sequence shared between both miR-33a and miR-33b had increased by almost 40 percent. For comparison, current therapies designed to increase HDL levels produce increases of 25 percent or less. Examination of the animals' livers showed increased expression of ABCA1 and other proteins known to be inhibited by miR-33 family members. Animals receiving anti-microRNA that targeted only miR-33a or miR-33b showed no increase in HDL levels, confirming that the two related microRNAs do have redundant effects. No adverse effects were seen in any of the animals.

"In addition to supporting this strategy for the treatment of cardiovascular disease, our study shows the importance of targeting multiple microRNA family members that may act redundantly to achieve therapeutic efficacy," says Näär, who is a professor of Cell Biology at Harvard Medical School. "We will be conducting required toxicology studies in rodents and non-human primates prior to a human Phase I safety trial."

INFORMATION:

Veerle Rottiers, PhD, of the MGH Cancer Center is lead author of the Science Translational Medicine report. Additional co-authors include Joshua Black, Hani Najafi-Shoushtari, PhD, and Johnathan Whetstine, PhD, MGH Cancer Center; Robert McGarrah, MD, Sumita Sinha, PhD, and Robert Gerszten, MD, MGH Cardiovascular Research Center; Andrew deLemos, MD, and Raymond Chung, MD, MGH Gastroenterology; and collaborators from Santaris Pharma in Denmark. Support for the study includes National Institutes of Health grants R21DK084459, R01DK094184, DK078772, DK093216-01A1, R01GM097360, CA059267, and RSG-13-115-01-CCG. The MGH has applied for patents on miR-33a and miR33b targeting for cardiometabolic disorders.

Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH conducts the largest hospital-based research program in the United States, with an annual research budget of more than $775 million and major research centers in AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, transplantation biology and photomedicine.

END



ELSE PRESS RELEASES FROM THIS DATE:

BU, MIT team engineers add new wrinkles to waterproofing

2013-11-21
BU, MIT team engineers add new wrinkles to waterproofing A surface that repels fluids faster VIDEO: The clock at top shows how fast a drop bounces off a relatively ...

Ancient Siberian genome reveals genetic origins of Native Americans

2013-11-21
Ancient Siberian genome reveals genetic origins of Native Americans Genetics The genome sequence of a 24,000-year-old Siberian individual has provided a key piece of the puzzle in the quest for Native American origins. The ancient Siberian demonstrates genomic ...

New health economics study highlights long-term benefits of rotator cuff surgery

2013-11-21
New health economics study highlights long-term benefits of rotator cuff surgery Understanding the full impact of treatments is important for patients with common shoulder injury Rosemont, Ill – Each year, close to 2 million people in the United States ...

Involving patients in their nurses' shift change reduces medical errors and satisfies patients

2013-11-21
Involving patients in their nurses' shift change reduces medical errors and satisfies patients TORONTO, Nov. 20, 2013 – At shift change, incoming and outgoing nurses transfer accountability by exchanging information about the patients under their charge. Called ...

What composes the human heart? U of T researchers crunch the numbers

2013-11-21
What composes the human heart? U of T researchers crunch the numbers A foundational study published in top biomedical journal PNAS (Proceedings of the National Academy of Sciences) this week by researchers at the University of Toronto's Institute of Biomaterials ...

Texas A&M: 24,000-year-old skeletal remains raise new questions about first Americans

2013-11-21
Texas A&M: 24,000-year-old skeletal remains raise new questions about first Americans COLLEGE STATION, Nov. 20, 2013 – Results from a DNA study of a young boy's skeletal remains believed to be 24,000 years old could turn the archaeological world upside down – it's ...

Aging erodes genetic control, but that's flexible

2013-11-21
Aging erodes genetic control, but that's flexible Fly study shows how heterochromatin changes with age, diet PROVIDENCE, R.I. [Brown University] — Biologists at Brown University have found a way to measure the effects of aging by watching the ebb and flow of ...

Let's just harvest invasive species -- problem solved?

2013-11-21
Let's just harvest invasive species -- problem solved? URBANA, Ill. – Although invasive Asian carp have been successfully harvested and served on a dinner plate, harvesting invasive plants to ...

NASA's TRMM satellite sees Melissa's tropical transition

2013-11-21
NASA's TRMM satellite sees Melissa's tropical transition VIDEO: This is a simulated 3-D flyby animation over subtropical storm Melissa using TRMM satellite data on ...

Sudden steep drop in blood pressure on standing from lying down may predict atrial fibrillation

2013-11-21
Sudden steep drop in blood pressure on standing from lying down may predict atrial fibrillation Johns Hopkins-led study suggests physicians check for heart rhythm disturbance in those with orthostatic hypotension Results of a Johns Hopkins-led study have identified ...

LAST 30 PRESS RELEASES:

AACR: Topical treatment offers relief from painful skin rash caused by targeted cancer therapy

Buprenorphine treatment in pregnancy and maternal-infant outcomes

Donor lungs safely preserved up to 20 hours out-of-body prior to transplantation

Experts at ISHLT report urgent need for pediatric heart support devices

DCD heart transplantation reaches 10-year mark, now up to 30% of transplant volumes

Immunotherapy before and after surgery improves outcomes in head and neck cancer

Donor hearts are traveling longer distances with machine perfusion

Six leading organizations unite to launch the pediatric heart transplant alliance

Effect of coupled wing motion on the aerodynamic performance during different flight stages of pigeon

Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training

Day-long conference addresses difficult to diagnose lung disease

First-ever cardiogenic shock academy features simulation lab

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

[Press-News.org] Tiny antisense molecules increase 'good cholesterol' levels in obese primates
Targeting shared nucleotide sequences can suppress family of gene-regulating microRNAs